Hi Good Morning [FIRST_NAME], •Oligonucleotide therapeutics represent a paradigm shift in precision medicine, targeting RNA to modulate gene expression with unmatched specificity for genetic and rare diseases. This eBook explores Evotec’s oligonucleotide journey and cutting-edge technologies on the path towards transformative precision medicine, featuring an exclusive interview with the CEO of Ionis Pharmaceuticals. Discover how RNA-targeted therapeutics like ASOs and siRNAs are revolutionizing pharmaceutical development with enhanced delivery, reduced off-target effects, and expert guidance from concept to clinic.
